XenoPort Company Profile (NASDAQ:XNPT)

About XenoPort

XenoPort logoXenoPort, Inc. is a biopharmaceutical company. The Company is focused on commercializing HORIZANT (gabapentin enacarbil) Extended-Release Tablets in the United States. The Company's segment is the development and commercialization of product candidates for the treatment of neurological and other disorders. Its development-stage product candidates include XP23829, XP21279 and arbaclofen placarbil. HORIZANT has been approved by the United States Food and Drug Administration for the treatment of moderate-to-severe primary restless legs syndrome in adults and for the management of postherpetic neuralgia in adults. XP23829 is a fumaric acid ester compound and a prodrug of metabolite monomethyl fumarate being developed for the treatment for patients with moderate-to-severe chronic plaque-type psoriasis and/or patients with relapsing forms of multiple sclerosis. XP21279 is a Transported Prodrug of levodopa being developed for the treatment for patients with idiopathic Parkinson's disease.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: XNPT
  • CUSIP: 98411C10
Key Metrics:
  • Previous Close: $7.07
  • 50 Day Moving Average: $6.71
  • 200 Day Moving Average: $5.20
  • 52-Week Range: $3.35 - $7.86
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -16.83
  • P/E Growth: 0.00
  • Market Cap: $N/A
  • Beta: 1.94
Additional Links:
Companies Related to XenoPort:

Analyst Ratings

Consensus Ratings for XenoPort (NASDAQ:XNPT) (?)
Ratings Breakdown: 1 Sell Rating, 1 Hold Rating, 1 Buy Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $5.50 (22.21% downside)

Analysts' Ratings History for XenoPort (NASDAQ:XNPT)
DateFirmActionRatingPrice TargetDetails
5/24/2016Jefferies GroupReiterated RatingBuyView Rating Details
5/6/2016Cowen and CompanyReiterated RatingHoldView Rating Details
1/19/2016Credit Suisse Group AGInitiated CoverageUnderperform$4.00View Rating Details
9/15/2015Royal Bank Of CanadaReiterated RatingBuy$10.00View Rating Details
(Data available from 10/26/2014 forward)


Earnings History for XenoPort (NASDAQ:XNPT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/5/2016Q116($0.21)($0.23)$14.24 million$14.12 millionViewN/AView Earnings Details
2/25/2016Q415($0.31)($0.21)$13.74 million$14.07 millionViewListenView Earnings Details
11/4/2015Q315($0.38)($0.38)$11.77 million$11.40 millionViewN/AView Earnings Details
8/5/2015Q215($0.32)($0.39)$9.77 million$8.60 millionViewN/AView Earnings Details
5/6/2015Q115($0.29)($0.33)$8.50 million$7.10 millionViewN/AView Earnings Details
2/19/2015Q414($0.34)($0.28)$7.10 million$7.10 millionViewN/AView Earnings Details
11/4/2014Q314($0.36)$0.13$6.30 million$31.10 millionViewN/AView Earnings Details
8/6/2014Q214($0.33)($0.31)$4.38 million$5.30 millionViewN/AView Earnings Details
5/8/2014Q114($0.32)($0.36)$3.86 million$3.40 millionViewListenView Earnings Details
2/20/2014Q413($0.45)($0.40)$3.35 million$2.90 millionViewListenView Earnings Details
11/4/2013Q313($0.51)($0.39)$3.03 million$2.52 millionViewN/AView Earnings Details
8/6/2013Q2 2013($0.53)($0.51)$1.74 million$2.10 millionViewN/AView Earnings Details
4/24/2013Q1 2013($0.43)($0.50)$1.20 million$4.59 millionViewN/AView Earnings Details
3/11/2013Q4 2012($0.42)$0.07$1.02 million$0.49 millionViewN/AView Earnings Details
10/24/2012Q312($0.43)($0.41)$2.26 million$0.40 millionViewN/AView Earnings Details
8/7/2012($0.39)($0.22)ViewN/AView Earnings Details
5/2/2012($0.22)($0.26)ViewN/AView Earnings Details
2/14/2012($0.39)($0.48)ViewN/AView Earnings Details
11/2/2011($0.44)($0.55)ViewN/AView Earnings Details
8/3/2011($0.23)$0.55ViewN/AView Earnings Details
5/5/2011($0.49)($0.49)ViewN/AView Earnings Details
2/16/2011($0.62)($0.47)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for XenoPort (NASDAQ:XNPT)
Current Year EPS Consensus Estimate: $-0.49 EPS
Next Year EPS Consensus Estimate: $-0.42 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.26)($0.26)($0.26)
Q2 20161($0.24)($0.24)($0.24)
Q3 20161($0.18)($0.18)($0.18)
Q4 20161($0.17)($0.17)($0.17)
(Data provided by Zacks Investment Research)


Dividend History for XenoPort (NASDAQ:XNPT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for XenoPort (NASDAQ:XNPT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/19/2016James E FlynnInsiderBuy20,973$3.99$83,682.27View SEC Filing  
2/12/2016James E FlynnInsiderBuy4,883,761$3.87$18,900,155.07View SEC Filing  
1/20/2016James E FlynnInsiderBuy346,417$4.09$1,416,845.53View SEC Filing  
9/1/2015Ronald W BarrettCEOSell12,500$7.00$87,500.00View SEC Filing  
7/15/2015Ronald W BarrettCEOSell12,500$7.20$90,000.00View SEC Filing  
7/13/2015Ronald W BarrettCEOSell12,500$7.00$87,500.00View SEC Filing  
5/11/2015Wendall WierengaDirectorBuy5,000$5.63$28,150.00View SEC Filing  
12/8/2014Gregory T BatesSVPSell14,166$8.35$118,286.10View SEC Filing  
12/8/2014Ronald W BarrettCEOSell7,015$8.36$58,645.40View SEC Filing  
12/5/2014Gianna M BoskoSVPSell60,000$8.45$507,000.00View SEC Filing  
9/9/2014Gregory T BatesSVPSell5,612$5.26$29,519.12View SEC Filing  
6/3/2014John Gordon FreundDirectorBuy12,500$3.93$49,125.00View SEC Filing  
5/27/2014Cathy FriedmanDirectorBuy2,600$3.92$10,192.00View SEC Filing  
5/23/2014John Gordon FreundDirectorBuy15,000$3.73$55,950.00View SEC Filing  
5/23/2014Ronald W BarrettCEOBuy2,600$3.75$9,750.00View SEC Filing  
5/15/2014Paul BernsDirectorSell2,500$3.66$9,150.00View SEC Filing  
4/24/2014Paul BernsDirectorSell2,500$4.30$10,750.00View SEC Filing  
6/14/2013Gregory T BatesSVPSell7,500$5.35$40,125.00View SEC Filing  
5/22/2013Ernest MarioDirectorBuy20,000$5.49$109,800.00View SEC Filing  
8/9/2012Ernest MarioDirectorBuy10,000$8.50$85,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for XenoPort (NASDAQ:XNPT)
News IconCarmot Therapeutics Appoints Aetna Wun Trombley, Ph.D. ... (NASDAQ:XNPT)
www.biomedreports.com - August 16 at 11:44 AM
News IconCarmot Therapeutics Appoints Aetna Wun Trombley, Ph.D. to the Board of Directors and Elena Viboch as Director of Business Development and Operations (NASDAQ:XNPT)
www.cbs58.com - August 16 at 11:44 AM
News IconAre Analysts Bullish XenoPort, Inc. (NASDAQ:XNPT) After Last Week? - Consumer Eagle (NASDAQ:XNPT)
www.consumereagle.com - July 21 at 8:44 PM
News IconArmistice Capital LLC Increased Xenoport INC (NASDAQ:XNPT) by $7.06 Million as Shares Declined - Consumer Eagle (NASDAQ:XNPT)
www.consumereagle.com - July 15 at 1:44 PM
News IconAre Analysts Bearish XenoPort, Inc. (NASDAQ:XNPT) After Last Week? - Consumer Eagle (NASDAQ:XNPT)
www.consumereagle.com - July 14 at 8:37 PM
News IconInsiders Increasing Positions in: Xenoport, Inc. (NASDAQ:XNPT) - Press Telegraph (NASDAQ:XNPT)
presstelegraph.com - July 14 at 8:37 PM
News IconArmistice Capital LLC Increased Xenoport INC (NASDAQ:XNPT) by $7.06 Million as Shares Declined - Press Telegraph (NASDAQ:XNPT)
presstelegraph.com - July 9 at 11:15 AM
News IconAre Analysts Bearish XenoPort, Inc. (NASDAQ:XNPT) After Last Week? - Press Telegraph (NASDAQ:XNPT)
presstelegraph.com - July 7 at 8:27 PM
streetinsider.com logoArbor Pharma Announces Results of XenoPort (XNPT) Tender Offer - StreetInsider.com (NASDAQ:XNPT)
www.streetinsider.com - July 5 at 7:58 PM
biz.yahoo.com logoXENOPORT INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure t (NASDAQ:XNPT)
biz.yahoo.com - July 5 at 4:54 PM
publicnow.com logoArbor Pharmaceuticals Completes Successful Tender Offer for Shares of XenoPort (NASDAQ:XNPT)
www.publicnow.com - July 5 at 6:51 AM
News IconArmistice Capital LLC Increased Xenoport INC (NASDAQ:XNPT) by $7.06 Million as Shares Declined - Engelwood Daily (NASDAQ:XNPT)
www.engelwooddaily.com - July 1 at 8:22 PM
kcregister.com logoFast Moving Stocks: Xenoport, Inc. (NASDAQ:XNPT), Kite Pharma, Inc. (NASDAQ:KITE), EMC Corporation (NYSE:EMC ... - KC Register (NASDAQ:XNPT)
www.kcregister.com - July 1 at 11:03 AM
News IconXenoport Incorporated (NASDAQ:XNPT) Short Interest Decreased By 8.34% - Engelwood Daily (NASDAQ:XNPT)
www.engelwooddaily.com - June 30 at 8:35 PM
streetinsider.com logoXenoPort (XNPT) Enters MOU Over Pending Merger; Agrees to Make Additional Disclosures (NASDAQ:XNPT)
www.streetinsider.com - June 28 at 8:20 PM
News IconInvestor News: Lawsuit against Buyout of XenoPort, Inc. (NASDAQ:XNPT) filed - GroundReport (NASDAQ:XNPT)
www.groundreport.com - June 27 at 8:06 PM
kcregister.com logoXenoport, Inc. (NASDAQ:XNPT) went up 0.29%: Chiasma, Inc. (NASDAQ:CHMA), United Technologies Corporation ... - KC Register (NASDAQ:XNPT)
www.kcregister.com - June 24 at 8:21 PM
istreetwire.com logoAnalytical Report: Xenoport, Inc. (NASDAQ:XNPT) - iStreetWire (NASDAQ:XNPT)
istreetwire.com - June 23 at 9:10 PM
marketwatch.com logoWhat Brexit Vote Could Mean for U.S. 2016 Election (NASDAQ:XNPT)
www.marketwatch.com - June 22 at 6:52 PM
News IconLawsuit for Investors in XenoPort, Inc. (NASDAQ:XNPT) in Effort to Halt Acquisition Filed - Digital Journal (NASDAQ:XNPT)
www.digitaljournal.com - June 22 at 5:29 AM
4-traders.com logoLawsuit for Investors in XenoPort, Inc. (NASDAQ:XNPT) in Effort to Halt Acquisition Filed (NASDAQ:XNPT)
www.4-traders.com - June 21 at 7:48 PM
moodys.com logoArbor Pharmaceuticals, LLC -- Moody's Assigns B1 CFR to Arbor Pharmaceuticals; Stable Outlook (NASDAQ:XNPT)
www.moodys.com - June 21 at 12:08 PM
fiscalstandard.com logoXenoPort, Inc. (NASDAQ:XNPT) Current Analyst Ratings - Fiscal Standard (NASDAQ:XNPT)
www.fiscalstandard.com - June 18 at 5:40 AM
finance.yahoo.com logoArbor Pharmaceuticals and XenoPort Announce the Expiration of the HSR Act Waiting Period (NASDAQ:XNPT)
finance.yahoo.com - June 16 at 6:30 AM
News IconInvestor News: Buyout of XenoPort, Inc. (NASDAQ:XNPT) faces Investigation over possible Breaches Of Fiduciary Duties (NASDAQ:XNPT)
www.groundreport.com - June 7 at 8:41 PM
finance.yahoo.com logoSurging Earnings Estimates Signal Good News for Xenoport (XNPT) (NASDAQ:XNPT)
finance.yahoo.com - June 6 at 8:55 AM
fool.com logoWhy Xenoport, Inc. Stock Jumped 61.1% in May (NASDAQ:XNPT)
www.fool.com - June 4 at 9:04 AM
News IconTakeover of XenoPort, Inc. (NASDAQ:XNPT) Under Investigation for Investors Concerning Potential Wrongdoing (NASDAQ:XNPT)
www.digitaljournal.com - June 3 at 9:09 PM
News IconBuy, Sell Or Hold Rating For XenoPort, Inc. (NASDAQ:XNPT)? - Share Trading News (NASDAQ:XNPT)
www.sharetrading.news - June 2 at 8:58 PM
thepointreview.com logoOverbuying Stock in the Spotlight: XenoPort, Inc. (NASDAQ:XNPT) - The Point Review (NASDAQ:XNPT)
www.thepointreview.com - May 31 at 11:20 AM
cchdailynews.com logoArmistice Capital LLC Increased Xenoport INC (NASDAQ:XNPT) by $7.06 Million as Shares Declined - CCH Daily News (NASDAQ:XNPT)
cchdailynews.com - May 28 at 11:41 AM
finance.yahoo.com logoSHAREHOLDER UPDATE: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of XenoPort, Inc. - XNPT (NASDAQ:XNPT)
finance.yahoo.com - May 27 at 10:13 PM
isstories.com logoStocks Update: Rock Creek Pharmaceuticals, Inc. (NASDAQ:RCPI) , XenoPort, Inc. (NASDAQ:XNPT) - Is stories (NASDAQ:XNPT)
www.isstories.com - May 27 at 12:46 PM
finance.yahoo.com logoXENOPORT SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Xenoport, Inc. (XNPT) Over the Proposed Sale of the Company to Arbor Pharmaceuticals, LLC (NASDAQ:XNPT)
finance.yahoo.com - May 26 at 4:16 PM
News IconFirst Majestic Silver Corp (NYSE:AG), XenoPort, Inc. (NASDAQ:XNPT) - NYSE Journal (press release) (NASDAQ:XNPT)
stockznews.com - May 26 at 11:50 AM
finance.yahoo.com logoThe Zacks Analyst Blog Highlights: XenoPort, Biodel and AbbVie (NASDAQ:XNPT)
finance.yahoo.com - May 26 at 9:30 AM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation Concerning Whether the Sale of XenoPort, Inc. to Arbor Pharmaceuticals, LLC for $7.03 Per Share is Fair to Shareholders -- XNPT (NASDAQ:XNPT)
finance.yahoo.com - May 25 at 3:12 PM
streetinsider.com logoArbor Pharma to Acquire XenoPort (XNPT) for $7.03/Share; Deal Valued at ~$467M (NASDAQ:XNPT)
www.streetinsider.com - May 25 at 11:44 AM
News IconAiling XenoPort (XNPT) Lifted on Buyout Announcement (NASDAQ:XNPT)
www.economiccalendar.com - May 25 at 11:44 AM
bizjournals.com logoArbor Pharmaceuticals to buy XenoPort for $467M (NASDAQ:XNPT)
www.bizjournals.com - May 25 at 11:44 AM
bidnessetc.com logoXenoPort Inc (XNPT) Stock Skyrockets on Arbor Merger Agreement (NASDAQ:XNPT)
www.bidnessetc.com - May 25 at 11:44 AM
equities.com logoXenoPort Inc. (XNPT) is Trading Higher on Unusual Volume for May 23 - Equities.com (NASDAQ:XNPT)
www.equities.com - May 25 at 12:55 AM
equities.com logoXenoPort Inc. (XNPT) Jumps 56.36% on May 23 - Equities.com (NASDAQ:XNPT)
www.equities.com - May 25 at 12:55 AM
thepointreview.com logoStock Overbuying in Action: XenoPort, Inc. (NASDAQ:XNPT) - The Point Review (NASDAQ:XNPT)
www.thepointreview.com - May 25 at 12:55 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of XenoPort, Inc. and Encourages Investors to Contact the Firm for Additional Information (NASDAQ:XNPT)
finance.yahoo.com - May 24 at 10:10 PM
capitalcube.com logoETF’s with exposure to XenoPort, Inc. : May 24, 2016 (NASDAQ:XNPT)
www.capitalcube.com - May 24 at 3:50 PM
bizjournals.com logoArbor Pharmaceuticals to buy XenoPort for $467 million (NASDAQ:XNPT)
feeds.bizjournals.com - May 24 at 2:57 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of XenoPort Inc. - XNPT (NASDAQ:XNPT)
finance.yahoo.com - May 24 at 12:31 PM
smarteranalyst.com logoMonday's Market Insights: Relypsa Inc (RLYP), Seadrill Ltd (SDRL), Nanosphere, Inc. (NSPH), XenoPort, Inc. (XNPT) - Smarter Analyst (NASDAQ:XNPT)
www.smarteranalyst.com - May 24 at 12:18 PM
kcregister.com logoHealthcare Unusual Volume: Xenoport, Inc. (NASDAQ:XNPT), Cellectar Biosciences, Inc. (NASDAQ:CLRB), Rock ... - KC Register (NASDAQ:XNPT)
www.kcregister.com - May 24 at 12:18 PM


XenoPort (NASDAQ:XNPT) Chart for Wednesday, October, 26, 2016

Last Updated on 10/26/2016 by MarketBeat.com Staff